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Prediction of the eﬀect of formulation on the
toxicity of chemicals†
Pritesh Mistry,a Daniel Neagu,a Antonio Sanchez-Ruiz,b Paul R. Trundle,a
Jonathan D. Vessey*b and John Paul Goslingc
Two approaches for the prediction of which of two vehicles will result in lower toxicity for anticancer
agents are presented. Machine-learning models are developed using decision tree, random forest and
partial least squares methodologies and statistical evidence is presented to demonstrate that they rep-
resent valid models. Separately, a clustering method is presented that allows the ordering of vehicles by
the toxicity they show for chemically-related compounds.
Introduction
When considering the formulation of a drug compound, many
factors must be taken into account: maintaining the eﬃcacy is
one of the most important, but for some classes of drug com-
pounds formulation to reduce toxicity becomes important too.
This is particularly true for cytotoxic compounds where several
formulation strategies to reduce toxicity have been used.1–6
Perhaps the simplest change in formulation is to change
the dosing vehicle. Investigations into the eﬀect of vehicle on
toxicity have been done in the past. For example, diﬀerences in
halocarbon toxicity using corn oil or an aqueous Emulphor
vehicle have been investigated by several groups7–11 with diﬀer-
ences in toxicity due to the vehicle also being dependent on
the type of toxicity – developmental, hepatotoxic and renal – as
well as the dose. Similarly, aliphatic nitrile compounds have
been investigated: Farooqui et al.12 showed that the toxicity of
unsaturated aliphatic nitriles in Sprague-Dawley rats was
reduced by using corn oil, saﬄower oil, mineral oil, olive oil or
Tween-20 rather than saline. In contrast, Ghanayem et al.13
found that administration of methacrylonitrile in saﬄower oil
was more toxic than in water.
The prediction of the toxicity of chemicals using machine-
learning methods has been underway for many years14–17 and
is suﬃciently mature to support both freely available18–21 and
commercial22–25 in silico models. Models are based on
mechanistic rationale (expert systems) or statistical corre-
lations, and both approaches have gained regulatory accep-
tance for prediction of mutagenicity of genotoxic impurities.26
In an earlier paper,27 we described the prediction of the
eﬀect of the dosing vehicle on toxicity; repurposed data from
the United States National Institute of Health (NIH)28 was used
to generate dose-survival curves for drugs administered using
either saline or carboxymethylcellulose (CMC), and it was
found that machine-learning (ML) methods could correctly
classify compounds as having lower toxicity when adminis-
tered with one of the two vehicles.
In this paper, we consider how to demonstrate that the
relationships that we found previously can be considered to be
statistically significant and use the same approach to establish
models for other pairs of vehicles.
As data for even a single compound tested using two
diﬀerent vehicles, with other factors being kept the same, are
rare, we have also investigated how clusters of compounds con-
taining similar chemical groups show a diﬀerence in toxicity
for vehicle pairs, allowing the building of sets of vehicles
ordered by their relative toxicity when used as vehicles for
compounds in the cluster.
Background
The dataset
The dataset that was used is described in detail in our previous
publication.27 The data have been collated over many years
between the 1950’s and 1980’s by the National Cancer
Institute’s Developmental Therapeutics Program (DTP).28 The
dataset was created to record the eﬀect of drug compounds on
animals that had been inoculated with a cancer cell line.
Experiments were done using sets of, typically, 6–10 animals
with variations in the dosing regime. Toxicity was measured by
considering the survival rate of the animals in the test on a par-
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ticular day. It is assumed that the death of the animals is due to
the administered compound rather than the cancer cell line due
to the short time span of the experiments, typically a few days.
The dataset consists of >2 M dose-toxicity data points; these
are generated from >220k diﬀerent compounds tested in ∼50
diﬀerent vehicles. There are experiments on ∼40 diﬀerent
species represented in the dataset with the drug compound
administered by ten diﬀerent routes.
The dataset is free to download with explanatory
instructions.28
The approach to measuring diﬀerences in toxicity
It was hoped that the dataset would contain records where the
only diﬀerence between two experiments was the vehicle with
which the compound was administered and that it would be
possible to measure a diﬀerence in toxicity where this was the
case. The toxicity was measured by the number of surviving
animals on a specified day. The diﬃculty in measuring the
diﬀerence in toxicity due to the vehicle was that relatively few
experiments were conducted with all other factors being the
same. In order to make a comparison between experiments,
therefore, a judgement was made about which factors must be
the same and which might be allowed to vary; the following
factors had to be the same for experiments to be considered
comparable: administered compound, route of administration,
host species, number of injections, injection interval, first
injection day, the number of repetitions, the day on which the
toxicity was assessed and any restart days. Where these factors
were the same, and the vehicle was also the same, the experi-
ments could be combined into an aggregate for these con-
ditions. In most cases (18 992 out of 26 424 for compounds
tested in either saline or CMC), there was only one set of dose-
survival experiments done in a compound-vehicle combi-
nation; in other cases, however, there were more. This means
that – for these aggregated data – there was both inter- and
intra-lab variability, both of which are diﬃcult to quantify.
5-Flurouracil is an anti-cancer agent which was tested many
times in the dataset, usually administered in saline and at
doses where a typical death rate was zero; this allows some
measure of both intra- and inter-lab variability. In 1985
diﬀerent sets of experimental conditions where more than one
experiment was performed by the same screener, 1687 (85%)
showed a median survival rate of 100%. Aggregating these to
eliminate diﬀerences from the screener gave 1576 diﬀerent
sets of experiments where more than one experiment was per-
formed of which 1325 (84%) showed a median survival rate of
100%. This suggested that both the intra- and inter-lab varia-
bility rates were low and were quite similar. Nevertheless,
some variability was observed: intra-lab variability is demon-
strated in Fig. 1 where six experiments involving the nitrogen
mustard para-di-(2-chlorethyl)-aminophenylalanine hydro-
chloride in CMC being administered by a single intraperito-
neal injection by the same screener are shown. Each experi-
ment is compared to its own control; experiments each lasted
a single day. The dose range in Fig. 1 is plotted logarithmically
for purposes of illustration. Two of the six experiments,
numbers 5 and 6, show exactly the same results. Three of the
six experiments demonstrate high toxicity in doses over
ca. 2500 mg per kg per injection. In the analysis in this paper,
the mean value of survival at each dose would be included in
the training data for the model.
Inter-lab variability is illustrated in Fig. 2 which shows the
results from six experiments where mercaptopurine was adminis-
Fig. 1 Dose-survival plot of six experiments involving single dose intra-
peritoneal injections of 4-di(2-chloroethyl)aminophenylalanine hydro-
chloride into B2D6F1 (BDF1) mice in CMC by the same screener.
Fig. 2 Dose-survival plot of six experiments by diﬀerent screeners
where mercaptopurine was administered to B2D6F1 (BDF1) mice, intra-
peritoneal, with a single daily injection repeated over nine days with the
drug administered using saline as the vehicle.
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tered to B2D6F1 (BDF1) mice, intraperitoneal, with a single
daily injection repeated over nine days with the drug adminis-
tered using saline as the vehicle; the dose range for each
experiment varies. For these experiments there is very little
variation in survival shown over the dose range, all studies
showing a survival of between 83 and 100%.
Fig. 3 shows the studies from Fig. 2 in the context of three
additional studies of the same regime but using CMC as the
vehicle. For these experiments, administering the drug in
saline generally results in a higher survival rate than adminis-
tering the drug in CMC.
Although generally there is a decrease in survival with
increasing dose, Fig. 1 and 2 show that, not infrequently, a set
of experiments shows a higher survival (i.e. less toxicity) at a
higher dose than at a lower dose: this is shown, for instance in
the experiments in Fig. 1 for Experiment 1 and Experiment 2
and also in Fig. 2 for Screener 2. Such variations are commonly
due to the death of a single animal from a study. In this work,
such variation is considered as ‘noise’.
Where the toxicity of a compound has been tested by
administering it using diﬀerent vehicles and these other
factors were equal, the toxicity profiles of the two experiments
were compared using the area under the dose-survival curve.
Where a diﬀerence in the areas under the dose-survival curve
was found, the compound is considered to be less toxic when
administered in one vehicle rather than the other.
As described previously,27 the diﬀerence in the area under
the dose-survival curve (AUC) could be calculated in diﬀerent
ways to maximise the areas compared: the three ways con-
sidered were interpolation only; interpolation with extra-
polation at the high dose end where possible and interpolation
with extrapolation at both ends of the dose range where
possible.
Interpolation is used where the lowest or highest doses
used in two experiments diﬀer; a point is added to the larger
dose range to estimate the survival at the ‘missing’ dose thus
defining a boundary for the calculation of the areas under the
dose-survival curves. Extrapolation at high dose is possible
where the survival has already fallen to zero and at low dose
where survival at the lowest recorded dose is 100%.
In Fig. 4, the diﬀerence in how the areas under the dose-
survival curves are calculated is illustrated for anthracene
dicarbamimidothioate (ATPU) hydrochloride administered to
B2D6F1 (BDF1) mice, intraperitoneal, with a single injection in
either saline or CMC. The area under the dose-survival curve
for the drug administered in saline is shown in pale red, while
that for the drug administered in CMC is shown in green; the
limits of the area under the curve are shown as blue vertical
lines. In the top diagram, it can be seen that at the highest
common dose, the survival rate in saline is 0% and so it is
reasonable to extrapolate this survival rate to higher doses, up
to log (dose per mg per kg per injection) of 4.8; this is shown
in the second diagram. Additionally, as the survival rate in
saline at the lowest common dose is 100% it is reasonable to
extrapolate to low dose and assume the survival rate will
remain the same; this is shown in the third diagram. (Note
that in Fig. 4, the dose axis is shown as log (dose per mg per
kg per injection). This is purely for purposes of the diagram.)
Across all the drug-vehicle combinations, it was found that
there was little diﬀerence in the number of compounds that
showed a diﬀerence depending on the method of measuring
the AUC, although when only using interpolation the median
was smallest; this is shown in Fig. 5.
In our previous paper we considered what would constitute
a suﬃciently significant diﬀerence in the area under the dose-
survival curve to merit a compound being considered to be
less toxic in one vehicle than another; three levels of diﬀerence
were considered: 30%, 40% and 60%. Clearly the greater the
diﬀerence needed to be considered significant, the fewer data
would satisfy the condition. This is shown in Fig. 6 where
increasing the diﬀerence in AUC needed to be considered sig-
nificant reduces the number of compounds fulfilling this con-
dition on going from 30% to 40% and 60%. In this paper, we
report the results from models built separately using all three
diﬀerences in AUC.
ML model building approaches
The idea of the ML model building was to see if it was possible
to build models which could classify compounds as more toxic
or less toxic when administered in one of two vehicles. The
classification of compounds in the training set would be made
by the diﬀerence in the dose survival curve for the compound
when administered in one vehicle over the other, other factors
Fig. 3 Variations in survival with dose for several experiments with
mercaptopurine. Each line represents an experiment carried out by
diﬀerent screeners. Lines in shades of blue or grey represent six experi-
ments where the mercaptopurine was administered in saline and lines in
shades of red and orange represent three experiments where the mer-
captopurine was administered in CMC.
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being the same. Frequently, it was found that where there were
several diﬀerent sets of experiments for a compound adminis-
tered in two vehicles – for example a set of experiments where
the host species was mouse, and a set of experiments where
the host species was hamster – it might be the case that a
Fig. 4 The dose-survival curves for anthracene dicarbamimidothioate
(ATPU) hydrochloride administered in saline and CMC. The area under
the saline curve is shaded in red and under the CMC curve in green. For
the model building, the areas under the curve to be compared are
shown by the blue vertical lines which change depending on whether
the curves are interpolated only (top), extrapolated at high dose (middle)
or extrapolated at both high and low dose (bottom).
Fig. 5 Boxplot of the variation in the number of compounds across all
vehicle pairs considered to show a signiﬁcant diﬀerence in the area
under the dose-survival curve with the interpolation or extrapolation of
data points.
Fig. 6 Boxplot of the variation in the number of compounds across all
vehicle pairs considered to show a signiﬁcant diﬀerence in the area
under the dose-survival curve with the size of the diﬀerence considered
to be signiﬁcant.
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reduction in toxicity was observed in a vehicle in one set of
experiments, but not in the other. Cases where compounds
did not show a consistent pattern across all the experiments
for a vehicle pair fell into two types: (i) those which showed a
combination of preference for one vehicle in some experi-
ments but no preference in other experiments, which were
termed equivocal and (ii) those which showed a preference for
one vehicle in some experiments and for the other vehicle in
other experiments, which were termed contradictory. The
number of equivocal compounds was often comparable to
those which showed a decided preference, whereas the
number that were actually contradictory was very small. For
the purposes of modelling, these equivocal and contradictory
compounds together with those compounds which consist-
ently showed no preference for either vehicle, were excluded;
numbers of compounds modelled as well as the numbers
excluded by being considered equivocal or contradictory are
shown in Tables 1 and 2.
The descriptors for the model were global physico-chemical
parameters such as log P or molecular weight as well as other
simple descriptors such as MACCS keys.
In the previous paper, we reported models built using
decision tree (DT) and random forest (RF) approaches; in this
paper, we also report the results of models built using a Partial
Least Squares (PLS) approach.
PLS is commonly used when there are a large number of
descriptors compared to the number of data points. It is also a
quantitative modelling approach, although refinements such
as PLS-Discriminant Analysis (PLS-DA)29 have been developed
for classification models. In the models reported in this paper,
a value of 0 or 1 was assigned to the preference of one vehicle
over another – for instance 0 would represent less toxicity in
CMC and 1 less toxicity in saline. The PLS model gave a
numerical value for the predicted vehicle with lower toxicity
that was assigned to a category (0 or 1) based on whether it
was greater than or less than 0.5. The approach has been used
successfully by others using PLS as a classification model.30
In all three approaches, the models were built using a
10-fold cross-validation approach. The folds were built ensur-
ing that the class ratio in the training sets matched that of the
dataset as a whole. Possible descriptors were correlated with
the observed classification of the compounds in the training
set and the most strongly correlating were selected. For the DT
and RF models the number of descriptors selected was equal
to one tenth of the number of compounds in the training set.
For the RF models, the random forest was rebuilt 100 times
each with a diﬀerent seed value, ensuring the RF models gave
rise to diﬀerent predictions. For the PLS models the number
of descriptors was varied in the range 5, 10, 20, 50; the
maximum number of components allowed in the PLS model
was one-tenth of the number of data points.
In all cases, the datasets to be modelled had to consist of at
least 50 compounds.
For each of the models, the metric that was used to
measure performance was the balanced accuracy of the classi-
fication. In practice it was found that the datasets being mod-
elled were quite balanced with all biases being 2.2 : 1 or less.
Statistical approach to validating the models
When considering if the results from a model are significant,
there are diﬀerent tests that need to be passed: are the results
from the model better than those that might be expected from
building a model where there is no relationship between the
feature being modelled and the descriptors used to build the
model; is there a rationale for why the descriptors used in the
model would be able to predict the activity modelled?
In this paper, the models are subjected to a rigorous stat-
istical analysis to demonstrate that they do indeed satisfy the
criteria for being considered statistically significant.
To this end, for each DT and PLS model where we wanted
to confirm that the prediction could not have occurred by
chance, 300 models were built using a y-randomisation
process31 (also known as target shuﬄing) in which the data-
sets from which the models were built had the preference for
Table 1 Performance of nine models for four diﬀerent vehicle pairs where the modelled dataset, N, was 50 compounds or more and the balanced
accuracy was at or above the 99th percentile of the distribution of balanced accuracies for 300 y-randomised models of the same data.
Interpolation/extrapolation is how the area under the dose-toxicity curve has been treated: interpolation only means no extrapolation has taken
place; high and high-low indicates that the data has been extrapolated at the high-dose or both the high- and low-dose ranges. AUC is the diﬀer-
ence in areas under the dose-survival curve needed before it is considered signiﬁcant. Equivocal is the number of compounds, not included in the
modelling, which showed lower toxicity in one vehicle in some experiments but no diﬀerence in others. Contradictory is the number of compounds
which showed lower toxicity for one vehicle in some experiments and for the other vehicle in other experiments. Percentile is the percentile of the
balanced accuracy of the real model in the distribution of balanced accuracies for the y-randomised models. HPC is hydroxypropylcellulose (Klucel)
Vehicle pair
Interpolation/
extrapolation AUC/%
N (less toxic in first
vehicle: second
vehicle) Equivocal Contradictory
Modelling
method
Balanced
accuracy Percentile
Saline vs. CMC Extrapolate high-low 40 123 (69 : 54) 100 14 PLS 76% 99.7
Saline vs. CMC Extrapolate high-low 40 123 (69 : 54) 100 14 DT 69% 100
Saline vs. CMC Interpolation only 60 66 (43 : 23) 55 2 PLS 83% 99.0
Saline vs. CMC Extrapolate high-low 60 79 (49 : 30) 76 4 PLS 85% 99.7
Saline vs. HPC Extrapolate high-low 30 116 (69 : 47) 42 3 PLS 80% 99.3
Saline vs. HPC Extrapolate high 30 131 (72 : 59) 44 3 DT 69% 99.7
Saline vs. saline with Tween-80 Extrapolate high-low 30 165 (92 : 73) 81 9 PLS 75% 99.0
HPC vs. saline with Tween-80 Extrapolate high-low 30 107 (56 : 51) 45 7 PLS 86% 99.7
HPC vs. saline with Tween-80 Extrapolate high 30 116 (59 : 57) 45 8 PLS 86% 100
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one vehicle over another randomised; descriptors were then
selected by correlation with the randomly assigned preference
and models built as previously.
For each DT and PLS model, the value of the balanced accu-
racy of the real model was compared with the distribution of
balanced accuracies from the y-randomised models. The
balanced accuracy of the real model was considered to show a
statistically significant diﬀerence to the distribution of the
balanced accuracies of the y-randomised models if it were in
or above the distribution’s 99th percentile, as calculated by the
empirical cumulative distribution function. Fig. 7 shows a
typical histogram of the distribution of balanced accuracies of
300 y-randomised PLS models for the classification of 123
compounds as having decreased toxicity in either saline or
CMC where the area under the dose-survival curve has been
calculated by extrapolating in both the high and low dose
regions and a diﬀerence in the AUC of 40% was needed in
order that the toxicities in the two diﬀerent vehicles was con-
sidered diﬀerent. Superimposed on the histogram is a normal
distribution with the same mean and standard deviation as
the distribution and the value of the balanced accuracy of the
real model. In this case the real model balanced accuracy is at
the 99.7th percentile of the distribution.
In the case of the RF models, 100 y-randomisations were
done and each y-randomisation was modelled 100 times to be
comparable with the set of real RF models. The question of
diﬀerence of the RF models from random thus involved com-
paring the distribution of balanced accuracies from the real
model with each of 100 distributions from the y-randomised
models. When comparing two distributions, it is straight-
forward to show whether or not they may be drawn from the
same distribution using a t-test, but we were interested in
measuring how much of an improvement over random each
Table 2 Summary of performance metrics and signiﬁcance measures for 100 RF models of each of 14 combinations of vehicle pairs, interpolation/
extrapolation and AUC signiﬁcance. Explanation of interpolation/extrapolation, AUC, N, equivocal and contradictory is given in Table 1
Vehicle pair
Interpolation/
extrapolation AUC/%
N (less toxic in first
vehicle : second
vehicle) Equivocal Contradictory
Mean
balanced
accuracy/%
Mean probability of
real model being
better than
random/% (SD)
Mean overlap
between real
and random
models (SD)
Saline vs. Water Extrapolate high 30 50 (29 : 21) 54 12 73 91 (20) 9 (16)
Saline vs. saline
with Tween-80
Extrapolate
high-low
40 119 (62 : 57) 53 6 63 85 (23) 16 (18)
Saline vs. MC Interpolation
only
30 60 (39 : 21) 19 3 69 81 (24) 17 (17)
Saline vs. HPC Interpolation
only
40 68 (36 : 32) 32 0 70 81 (28) 13 (16)
Saline vs. CMC Interpolation
only
60 66 (43 : 23) 55 2 71 94 (17) 8 (14)
Saline vs. CMC Interpolation
only
40 108 (68 : 40) 87 9 63 84 (27) 15 (16)
Saline vs. CMC Interpolation
only
30 144 (95 : 49) 106 18 62 90 (21) 12 (16)
Saline vs. CMC Extrapolate high 60 92 (58 : 34) 70 6 79 100 (1) 0 (0)
Saline vs. CMC Extrapolate high 40 130 (78 : 52) 99 15 63 91 (21) 13 (20)
Saline vs. CMC Extrapolate high 30 164 (103 : 61) 112 26 61 89 (22) 13 (17)
Saline vs. CMC Extrapolate
high-low
60 79 (49 : 30) 76 4 73 98 (11) 3 (7)
Saline vs. CMC Extrapolate
high-low
40 123 (69 : 54) 100 14 66 94 (14) 10 (15)
HPC vs. saline
with Tween-80
Interpolation
only
40 62 (26 : 36) 32 5 71 88 (23) 7 (9)
HPC vs. saline
with Tween-80
Extrapolate
high-low
30 107 (56 : 51) 45 7 66 88 (23) 7 (12)
Fig. 7 Histogram of the balanced accuracies of y-randomised PLS
models for the classiﬁcation of 123 compounds as having their toxicity
reduced by either saline or CMC, in green. The blue line represents a
normal distribution having the same mean and standard deviation as the
distribution of balanced accuracies from the y-randomised models. The
red line indicates the balanced accuracy of the model built with the real
classiﬁcation of the 123 compounds.
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experiment represented. Two approaches to this were
investigated.
Firstly, quantifying the overlap, as shown in Fig. 8, between
the distribution of real balanced accuracies and each of the
distributions of y-randomised balanced accuracies. An approxi-
mation to the overlap proportion for the two distributions was
done by (1) partitioning the balanced accuracy and producing
histographic density estimates over the partition for both of
the distributions and (2) adding up the minimum density for
each partition. For completely separate distributions the
overlap would be zero whilst for a situation where the real and
random models produced identical distributions the overlap
would be 100%. The distributions of the y-randomised models
for 45 diﬀerent combinations of vehicle pair and modelling
conditions showed a fair amount of consistency, with median
values between 55% and 64%; as a result, real models with a
low performance (i.e. models which would fail the validation
process) could still show a low overlap – so it was important to
measure only those cases where the median of the distribution
of balanced accuracies from the real models was greater than
that of the y-randomised ones. In this study, the value of the
overlap is recorded but not used by itself as a discriminating
value for the significance of the experiment. The overlap coeﬃ-
cient remains popular for comparing two population distri-
butions in many fields.32,33
The second approach to measuring the improvement of the
real model over the set of y-randomised models involved esti-
mating the chance that a value taken at random from the dis-
tribution of balanced accuracies of the real models was greater
than one taken from each of the distributions of balanced
accuracies from the y-randomised models. As this is a Monte
Carlo procedure, it is also trivial to calculate standard errors
for the probability estimate.
For the collection of RF models to be considered as having
outperformed the y-randomised models, the mean of the
above probability value had to be greater than 80%. This was
an arbitrary cut-oﬀ, but there is little previous work to suggest
an alternative.
ML model building results
DT and PLS models
The results of the DT and PLS experiments are summarised in
Table 1 for those combinations of vehicle pair, interpolation/
extrapolation and AUC significance where the performance
based on balanced accuracy was found to be at or above the
99th percentile of the distribution of balanced accuracies of
the 300 corresponding models built from y-randomised data
as calculated by the empirical cumulative distribution
function.
As can be seen, both in quantity of models and in their
overall performance the PLS modelling technique yields better
results than the DT technique. Four of the combinations are
for compounds where a diﬀerence in toxicity is observed when
using saline and CMC, though the best performing – in terms
of both balanced accuracy and improvement over the y-ran-
domised models are the datasets of compounds where the
comparison is between HPC and saline with Tween-80.
RF models
There were 14 combinations of vehicle pair, interpolation/
extrapolation and AUC significance, covering six diﬀerent
vehicle pairs, where the RF models were considered as signifi-
cantly outperforming random.
In Fig. 9 the distributions of probabilities that the real
model outperforms a y-randomised model are shown for the
14 combinations where the mean of the distribution was 80%
or more. Note that the medians of these distributions tend to
be 90% or more. Eight of the combinations relate to the saline
vs. CMC pair, i.e. out of the nine possible combinations of
interpolation/extrapolation and AUC significance for this
vehicle pair, eight are considered to allow the building of RF
models which outperform random. Of particular note are the
results for the set of 92 compounds where, when the dose-
survival curve is extrapolated only at the high dose range and a
threshold of 60% is used for the diﬀerence in the AUC of the
dose-survival curve, 100 RF models were built and all but one
had a probability of 100% that they outperformed a model
built on y-randomised data (i.e. all but one had zero overlap
between the distributions of balanced accuracies of the real
and y-randomised models).
The results in Table 2 give more details of these sets of
models and it can be seen that the mean of the overlap in
balanced accuracy distribution is always <20%.
Fig. 8 Histograms of balanced accuracy for real (blue) and one of the
100 y-randomised (red) models of 107 compounds which show a diﬀer-
ence in toxicity between HPC and saline with Tween-80, extrapolating
the dose-survival curve in both the high- and low-dose regions and
using a diﬀerence in the AUC of the dose-survival curve of 30% as
showing a diﬀerence in toxicity. The purple area indicates the overlap of
the two distributions.
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Whilst considering that the models all show a performance
which can be considered statistically significant, the actual
balanced accuracies of the RF models are modest – in the
range 61–79% – so are less than the PLS models. As with the
DT and PLS models, the performances of the models for the
compounds which show a diﬀerence in toxicity between saline
and CMC are among the best. This suggests that not only can
this diﬀerence in toxicity due to the dosing vehicle be mod-
elled but that the descriptors used in making the models
capture well which compounds will show that diﬀerence.
RF model analysis
The performance of the models and the demonstration of
their statistical significance suggests that they merit some
investigation to see if the descriptors that are found to be sig-
nificant can be rationalised.
One of the main reasons for variation in formulation –
including variation in administration vehicle – is ensuring the
drug compound is held in solution or in an emulsion or gel
and so prevented from precipitating. For instance, cellulose-
derived vehicles are thought to form a complex with the drug
where the vehicle encapsulates the drug compound and there-
fore will change not only the solubility but the distribution of
the drug compound.
There are a few studies where the eﬀect of vehicle on toxi-
city is understood, for example nitrogen mustards have been
used as cytotoxic drugs and are known to have their toxicity
(and anti-tumour activity) reduced in acid media34,35 due to
the protonated nitrogen being unable to form the reactive azir-
idinium ion.36 However, as far as we know, there is little syste-
matic work rationalising the eﬀect of vehicle on toxicity and it
is hoped that this work might help in such a study.
To that end a set of 100 RF models of the whole dataset
(rather than cross-validation subsets) for classifying com-
pounds as less toxic in either saline or CMC using the settings
of the best performing model (interpolation/extrapolation set
to ‘extrapolate high’ and significance threshold set to 60%)
was analysed to see which were the most impactful descriptors
in the models. This study was done using RF models deve-
loped in R (which has the same RF algorithm as the KNIME
Weka nodes used in the modelling reported above). The
results are shown in Table 3.
In this case there is a high degree of similarity between the
descriptors influencing the prediction of lower toxicity in
saline and lower toxicity in CMC. In addition, it can be seen
that the descriptors reflect substructural features rather than
whole structure properties such as solubility, log P or mole-
Fig. 9 Boxplots of mean probability that a RF model outperforms a y-randomised model for 14 combinations of vehicle pair, interpolation/extra-
polation and AUC signiﬁcance. Experiments with the same vehicle pair are shown in the same colour.
Table 3 Most impactful descriptors in RF models of toxicity of com-
pounds in saline or CMC. RDKit, Indigo and CDK MACCS are the sources
of diﬀerent descriptors
Descriptor
Saline > CMC
rank
CMC > saline
rank
Indigo number of heteroatoms 1 1
RDKit number of Lipinski hydrogen
bond acceptors
2 4
Indigo number of aliphatic atoms 3
CDK MACCS key 160: CH3 4 5
CDK MACCS key: 137 Heterocycle 5
CDK MACCS key: 109 ACH2O 2
MACCS key: 120 Heterocyclic atom > 1 3
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cular weight (all of which were available to the RF models).
The descriptors, three of which were also found to be signifi-
cant in our earlier study,27 also suggest a relationship with the
ability to form hydrogen bonds through the presence of a
heteroatom/heterocycle or an explicit count of hydrogen bond
acceptors. Further analysis of the descriptors is beyond the
scope of this work.
In terms of application of the models, whilst the statistical
analysis presented here shows that it is indeed possible to
model the influence of the vehicle on toxicity, without a scien-
tific rationale the models can only be used as a starting
point for suggesting formulation strategies. There is insuﬃ-
cient data to attempt refinements such as species specific
formulations.
Investigation into diﬀerences shown
by clusters of compounds
Among the datasets which contained fewer than 50 com-
pounds, there were a few results of note. In particular, the
vehicle pairs of distilled water & alcohol (DWA) vs. CMC all the
models correctly classified groups of 11 or 14 compounds
entirely correctly. The datasets that were classified correctly
were all classified in the same way: compounds containing an
aziridine ring were classified as less toxic in CMC than in
DWA; all the compounds showing the reverse toxicity profile
did not contain an aziridine ring (and, further, did not
contain any other obvious common feature). Of the com-
pounds containing an aziridine ring, many of them were
diaziridylphosphoramides (DAPs) with the substructure shown
in Fig. 10.
This finding suggested that a clustering approach could be
taken to investigate diﬀerences in toxicity for related com-
pounds between sets of vehicles.
Using the DAP structure shown in Fig. 10 to search the
complete dataset for compounds with this substructure, 22
compounds were found for which there were data where the
compound had been administered in both DWA and CMC.
With such a small sample, the preference for CMC vs. DWA
was examined with no threshold for the diﬀerence in the area
under the dose-survival curve, but some rigor was introduced
by considering that the area comparison had to be in the same
direction however the interpolation or extrapolation were
made and this was true irrespective of all other variable factors
in the data, so the 22 compounds were represented by 28 sets
of experiments where both CMC and DWA had been used. The
areas under the curve were considered using all three inter-
polation/extrapolation strategies and found that a core group
of 17 compounds always showed less toxicity in CMC, 4 always
showed less toxicity in DWA and one always showed no
preference.
It appears therefore, that drug compounds with the sub-
structure shown in Fig. 10 might generally be formulated in
CMC to reduce toxicity over a DWA vehicle.
Other diﬀerences for compounds with the substructure in
Fig. 10 were investigated. For the four vehicles saline, CMC,
MC and DWA, 83 compounds were found with data for at least
one pair. In analysing the distribution of compounds between
vehicle pairs, the approach taken was that a diﬀerence in toxi-
city was considered to be shown if the number of compounds
with lower toxicity in one vehicle was greater than the number
with lower toxicity in the other vehicle plus the number
showing no diﬀerence in toxicity; where this was not the case,
it was considered that the cluster of compounds showed no
diﬀerence between the vehicle pair. Thus, for the 83 com-
pounds containing the DAP structure, where the distribution
between each pair is shown in Table 4, and as reported above,
it is considered that the cluster shows less toxicity in CMC
compared to a vehicle of DWA by 17 to 4 with one showing no
diﬀerence. Similarly, the cluster shows less toxicity in CMC
than in MC by 9 to 5, again with one compound showing no
diﬀerence.
The data in Table 4 show a self-consistent set of relation-
ships in the order of the toxicity of the four vehicles with
respect to compounds defined by the substructure shown in
Fig. 10, which can be expressed as saline > CMC > MC > DWA
where ‘>’ means ‘shows greater survival than’; the relation-
ships are represented graphically in Fig. 11. These results
could be considered to be a small rule base for choosing a
vehicle for DAP drug compounds. It is important to be aware
that these are trends for the cluster of 83 DAP compounds and
not for individual compounds. Indeed, only one compound of
the 83, ThioTEPA, had data for all six pairs, and ThioTEPA
itself did not follow all the rules. Nevertheless, ThioTEPA is
commonly administered in distilled water or saline.37,38
Fig. 10 Diaziridylphosphoramide (DAP) derivatives which were seen to
show a diﬀerent toxicity proﬁle in CMC than in distilled water & alcohol.
Table 4 Diﬀerences in toxicity found for clusters of compounds con-
taining the DAP structure shown in Fig. 10, aziridines and phosphor-
amides. Figures in italics indicate that there is not considered to be a
diﬀerence in toxicity shown by the two vehicles in the pair
Less toxic
vehicle
More toxic
vehicle
Preference ratio shown by cluster
(less toxic : more toxic : no diﬀerence)
DAPs Aziridines
NP(= [O,S])
(N)(N)
CMC DWA 17 : 4 : 1 26 : 17 : 3 14 : 2 : 1
Saline DWA 22 : 11 : 0 30 : 18 : 3 11 : 4 : 0
MC DWA 8 : 5 : 0 12 : 12 : 5 —
CMC MC 9 : 5 : 1 19 : 12 : 3 —
Saline CMC 18 : 7 : 9 39 : 18 : 17 13 : 7 : 9
Saline MC 7 : 3 : 1 15 : 8 : 5
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Other clusters of compounds were investigated. A related
cluster of 149 compounds containing an aziridine ring showed
similar relationships between the four vehicles, although as
the number of compounds found to be less toxic when adminis-
tered with MC rather than DWA was not greater than the
number of compounds showing the reverse relationship and
the number showing equality, the relationships between the
four vehicles could be expressed as saline > CMC > MC = DWA,
where, again, ‘>’ means ‘shows greater survival than’ and ‘=’
means ‘shows the same survival as’. In contrast, for a cluster of
38 phosphoramides defined with the SMARTS string NP(= [O,S])
(N)(N) there were only enough data for the relationships
between three of the vehicles (see Table 4) and the relationships
were saline = CMC > DWA.
The preference ratios for the three clusters represent fully
ordered sets where all the relationships have suﬃcient – and
non-contradictory – data. For a cluster of 63 platinum contain-
ing compounds, data were found for five of the six diﬀerent
vehicle pairs from saline & Tween-80, HPC, water and saline.
For these compounds there was insuﬃcient data for the saline
& Tween-80 vs. water combination. However, the five relation-
ships which were found suggested the toxicity for platinum
containing compounds varied saline > HPC = water > saline &
Tween-80 and gave a full ordering of the four vehicles as can
be seen in Fig. 12.
With a set of 54 compounds containing a sulphonic acid
group, including compounds with an alkyl sulphonate counter-
ion, with the vehicles sonified saline, saline, saline &
Tween-80 and HPC, data were found again for five of the six
possible relationships and were again able to form a fully
order set. In this case there was no preference shown between
saline, saline & Tween-80, and HPC so the relationships can be
summarised as sonified saline > saline = saline & Tween-80 =
HPC as shown in Fig. 13.
The five clusters of compounds referred to in this section,
together with the vehicle shown to be less toxic from each pair
for which there are data are supplied as SD files in the ESI.†
Several other experiments on clusters defined by groups
such as arsenic compounds, nitrogen mustards, quinones, aryl
carboxylic acids or simply multi-component compounds were
also performed but resulted only in equivalency of several
Fig. 11 Relationships between diﬀerent toxicity proﬁles for compounds
of the DAP shown in Fig. 10. Arrows go from the vehicle with the lower
toxicity to the vehicle with the higher toxicity (i.e. ‘safer’ to ‘less safe’).
Labels on the arrows indicate the number of DAPs which are found for
the vehicle pair to be less toxic : more toxic : no diﬀerence. A similar
arrangement of nodes can be drawn for the aziridines and a subset of
the nodes can be drawn for the phosphoramides.
Fig. 12 Relationships between diﬀerent toxicity proﬁles for a cluster of
63 platinum-containing compounds. Arrows go from the vehicle with
the lower toxicity to the vehicle with the higher toxicity (i.e. ‘safer’ to
‘less safe’). Labels on the arrows indicate the number of compounds
which are found for the vehicle pair to be less toxic : more toxic : no
diﬀerence. Where two or more vehicles are not considered to show a
diﬀerence in toxicity, a double headed arrow is used and the label indi-
cates less toxic on the left : less toxic on the right : no diﬀerence.
Fig. 13 Relationships between diﬀerent toxicity proﬁles for a cluster of
54 sulphonic acids. Arrows go from the vehicle with the lower toxicity to
the vehicle with the higher toxicity (i.e. ‘safer’ to ‘less safe’). Labels on
the arrows indicate the number of compounds which are found for the
vehicle pair to be less toxic : more toxic : no diﬀerence. Where two or
more vehicles are not considered to show a diﬀerence in toxicity, a
double headed arrow is used and the label indicates less toxic on the
left : less toxic on the right : no diﬀerence.
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diﬀerent vehicles, or single vehicle pair relationships which
could not be put in a wider context. There were also cases
where inconsistent relationships were recorded for example
among a cluster of nitrogen mustards the inconsistent
relationships HPC > saline & Tween-80, CMC = HPC, CMC =
saline & Tween-80 were found. Nevertheless, the self-consistent
sets of relationships found in the discussion above suggests
the approach has some merit.
Experimental work
The dataset was provided by the National Institute of Health’s
Developmental Therapeutics Program28 and was curated as
described previously27 to give a dataset of 2 297 845 records
relating to 221 656 drug compounds. 52 diﬀerent vehicles were
considered giving 1326 unique vehicle pairs.
All modelling and clustering were done with KNIME version
2.12.2. In this environment, descriptors were obtained from
the RDKit and Indigo descriptor nodes and CDK MACCS
fingerprints node; PLS models were built with the Weka 3.6
nodes, RF models were built with Weka 3.7 nodes and DT
models were built with the KNIME base nodes. Statistical ana-
lyses were performed using R nodes running version 3.0.3 of
R sub versioned 201508240951. Chemical substructure
searches were performed using the RD Kit Substructure filter.
KNIME workflows representative of the experiments
reported in this paper are available as ESI.†
Conclusions
We have shown that models can be made for classifying which
of a pair of vehicles for a drug compound can result in lower
toxicity.
We have demonstrated that the approach works for several
pairs of vehicles, and that a statistically rigorous evaluation of
the results demonstrates that they have not come about by
mere chance. We find that models built using PLS techniques
give better predictive performance than those built with RF or
DT methods.
We have also presented a method of ordering the relative
toxicities shown by vehicle pairs for a series of clusters which
generally lead to self-consistent ordered sets of vehicles.
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